LXRP

Lexaria Bioscience (QX) Stock Price

0.265
-0.00675 (-2.48%)
0.265
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corporation (QX) LXRP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00675 -2.48% 0.265 16:29:22
Close Price Low Price High Price Open Price Previous Close
0.265 0.265 0.28 0.28 0.27175
Bid Price Ask Price Spread News
0.256 0.3058 0.0498 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
30 49,182 $ 0.275042 $ 13,527 102,728 0.2179 - 0.76
Last Trade Time Type Quantity Stock Price Currency
15:57:40 2,500 $ 0.265 USD

Lexaria Bioscience (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 23.86M 90.04M 62.05M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.73k $ - 0.00% - -

more financials information »

Lexaria Bioscience (QX) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2650.320.2540.2723385194,0960.000.0%
1 Month0.320.35950.2540.2918011118,177-0.055-17.19%
3 Months0.26930.52120.23690.3192812108,073-0.0043-1.6%
6 Months0.2490.52120.21790.3068753107,0890.0166.43%
1 Year0.70760.760.21790.3841598105,131-0.4426-62.55%
3 Years0.3952.540.21791.24180,643-0.13-32.91%
5 Years0.18792.540.080.940816164,7620.077141.03%

Lexaria Bioscience (QX) Description

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October. 2016. Lexaria's technology provides increases of up to 1Ox in intestinal absorption rates; more rapid delivery to the bloodstream with effects often with in 15-20 minutes; and important taste-masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.